Cerebral proliferative angiopathy is a rare type of cerebral vascular malformation. It shows distinct angiomorphological features with a clinical presentation that differs to that of classic arteriovenous malformation of the brain. We describe a 15-year-old girl who presented with recurrent headache and limb weakness. A subsequent angiographic diagnosis of cerebral proliferative angiopathy was made. The clinical features, pathophysiology, and treatment of this condition are reviewed.
Cerebral proliferative angiopathy (CPA) is a rare and under-recognised cerebral vascular malformation. It is distinct to classic types of brain arteriovenous malformation (AVM) with pathognomonic angiographic findings. One of the major findings in CPA is the presence of brain parenchyma within the nidus of the lesion. Patients with CPA tend to present at a younger age, typically around age 22 years, 1 with fewer haemorrhages. Cerebral ischaemia is an important feature of this condition with implications for treatment strategy.
2 Similar to diffuse AVMs, there may be disease progression and treatment can be challenging. 3 We present a case of CPA diagnosed by computed tomography (CT), magnetic resonance imaging (MRI), and digital subtraction angiography (DSA).
CASE PRESENtAtiON
A 15-year-old girl was admitted in March 2015 to a local hospital in Hong Kong for sudden-onset right-sided headache associated with left-sided limb weakness. She vomited twice. Further history revealed recurrent rightsided headaches and left-sided weakness for 6 months. The limb weakness usually lasted for 30 minutes and then resolved spontaneously. No photophobia or visual blurring was noted and there was no history of convulsion. Physical examination revealed no focal neurological deficit.
Brain CT scan after admission showed subtle loss of grey-white matter differentiation in the right frontal lobe with sulcal effacement (Figure 1a ). Nonetheless there was little mass effect and no associated oedema. In view of suspected underlying vascular or mass lesions, urgent brain MRI was performed. Fluid-attenuated inversion recovery (FLAIR) images showed a serpiginous low signal in the right frontal lobe and high right parasagittal parietal lobe compatible with abnormal vessels (Figure  1b The overall imaging findings, particularly those of multiple arterial feeders, intermingling with normal brain parenchyma and a relatively small amount of shunting suggested the diagnosis of CPA. Because there was no history of bleeding, a high risk from intervention and relatively mild symptoms, she was managed conservatively.
DiSCUSSiON
Classic cerebral AVM refers to an abnormal transition between an artery and vein through a nidus. There is prominent shunting of blood from the arterial to the venous side. 4 This is a relatively uncommon entity. Nonetheless in the review by Lasjaunias et al, 1 about 3.4% of brain AVMs showed features distinct from classic brain AVM and these cases are termed CPA.
Angiomorphologically, CPA differs to classic AVM by the absence of dominant feeders or flow-related aneurysms, presence of proximal stenosis of the feeding arteries, extensive transdural supply to both healthy and pathological tissue, large size, presence of capillary angioectasia and only moderately enlarged veins.
1 As seen in this case, the anterior, middle, and posterior cerebral arteries contributed to the vascular malformation. The draining veins were smaller than expected for an AVM of this size.
Histopathological study shows that the major difference between classic AVM and CPA, as seen in imaging studies, is the presence of identifiable neurons and normal brain tissue between the abnormal vessels in CPA. This is somehow analogous to capillary telangiectasia. 5 It is possible that CPA results from an early embryological event during angiogenesis. 6 One of the underlying causes may be hypoperfusion, as shown in perfusion-weighted MRI study. 7 This contrasts with classic AVM in which marked shunting is present. This hypoperfusion might lead to an uncontrolled angiogenic response, thus giving it its "proliferative" nature. Moreover, MRI perfusion study in our case demonstrated subtle increase in mean transit time in the involved region. The proposed mechanism for such finding is venous congestion with consequent ischaemia in the involved brain parenchyma. Ducreux et al 8 described one patient with identical MR perfusion findings that corresponded to increased regional vascularity with slow venous drainage on conventional angiography. Transdural supply is also thought to be a response to the ischaemic nature, 9 as seen in our patient with vascular supply from the external carotid artery territory. In addition, previous studies have also demonstrated reduced cerebrovascular reserve in these patients. 10 The role of vascular endothelial growth factor (VEGF) in this condition is also being investigated, with reports showing an increased level of cerebrospinal fluid VEGF level in CPA patients.
11
Clinically, CPA tends to present in younger patients with a female-to-male ratio of 2:1 compared with the almost equal gender distribution in classic AVM.
1 Frequent presenting symptoms include seizure, headache, and progressive neurological deficits. Acute haemorrhage or neurological deficit are relatively less frequently encountered. Nonetheless when there is haemorrhage, the risk of re-bleeding becomes much higher, possibly due to vulnerability of newly formed vessels.
1
There is currently no standard treatment for CPA. The usual treatment strategies of embolisation, surgery, or radiosurgery 1,2 all carry significant risks of injury to normal brain parenchyma since there is neuronal tissue interspersed with the abnormal vessels. Patients with haemorrhage, uncontrolled seizure or disabling headaches may still be managed by embolisation or surgery. 1, 12 Since ischaemia is one of the pathogenic mechanisms of this condition, treatments aimed at improving blood supply to the ischaemic brain may be of value. This is analogous to cases of moyamoya disease. 2 Burr holes have been advocated by some as a means to improve the symptoms by increasing cortical blood supply through recruitment of additional dural blood supply.
Encephaloduroarteriosynangiosis has also been reported to improve perfusion to the brain. 13 No established medical treatment is available for CPA at present. Although the use of anti-VEGF in AVM has been recommended, its role in CPA requires further investigation. 2, 13 The use of radiotherapy has also been recently reported in the literature. In one reported patient with CPA, the patient presented with clinical and radiological response after radiation therapy.
14 Like other brain vascular lesions, there may be progression of the vascular abnormality. 1, 2 Whether to treat CPA patients with relatively mild symptoms and when to offer treatment remain uncertain. Further studies are required to delineate the pathogenic mechanism and natural history of this condition.
In conclusion, CPA is a rare and distinct type of cerebral vascular malformation. Clinicians and radiologists should be aware of this entity when encountering patients with vascular malformation of the brain and planning treatment.
